Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Active Post-Market Surveillance Study Assessing the Real-World Clinical Applicability, Long-Term Safety, and Effectiveness of Innovative Medical Devices for Valvular Heart Disease

NCT07605624 is registered in ClinicalTrials.gov with Beijing Anzhen Hospital as lead sponsor.

NCT NCT07605624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07605624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Active Post-Market Surveillance Study Assessing the Real-World Clinical Applicability, Long-Term Safety, and Effectiveness of Innovative Medical Devices for Valvular Heart Disease
Lead sponsor
Beijing Anzhen Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
May 10, 2026
Completion date
January 31, 2029
Enrollment
5,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic regurgitation, aortic stenosis, mitral regurgitation, tricuspid regurgitation